Faeth Therapeutics, Inc. ( FTH) - Key Metrics
FTH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$2.84 | -$2.78 | -$2.78 |
| 2026Q1 | $0 | -$131.45 | -$8.29 | -$8.29 |
| 2025Q4 | $0 | -$3.74 | -$3.06 | -$3.06 |
| 2025Q3 | -$3.85 | -$3.62 | -$2.84 | -$2.84 |
| 2025Q2 | $0 | -$3.91 | -$4.69 | -$4.70 |
FTH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.20 |
| 2026Q1 | 0% | -0.06 |
| 2025Q4 | 0% | -0.71 |
| 2025Q3 | 0% | -0.65 |
| 2025Q2 | 0% | -0.55 |
FTH
Price: $33
52 week price:
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 34.2 million